Actionable news
All posts from Actionable news
Actionable news in GNCA: GENOCEA BIOSCIENCES Inc,

Cowen Offers Commentary on Two Biotech Stocks: MEI Pharma Inc (MEIP), Genocea Biosciences Inc (GNCA)


Cowen analysts came out today with an optimistic view on the oncology company MEI Pharma Inc (NASDAQ:MEIP) and vaccine development company Genocea Biosciences Inc (NASDAQ:GNCA), as the iShares Nasdaq Biotechnology ETF (IBB) tried to recover recent losses with gains of nearly 2% today.

MEI Pharma Inc

Cowen analyst Boris Peaker reiterated an Outperform rating on shares of MEI Pharma, after the company announced that data from its Phase II clinical studies of Pracinostat in elderly acute myeloid leukemia (AML) and previously untreated myelodysplastic syndrome (MDS) have been selected by the American Society of Hematology (ASH) Program Committee for oral presentation at the 57th ASH Annual Meeting & Exposition in Orlando on December 7, 2015.

Peaker noted, “We expect to see survival data at ASH and believe anything beyond 1 year warrants Phase III development.” Furthermore, “Also expected at ASH is the first look at Phase II MDS data. To date, all that has been reported was that the study of pracinostat in combination with Vidaza in front-line MDS had missed its primary CR endpoint. We would not dismiss this study completely as we expect to see...